October 2, 2024 01:39 PM EDT
FDA+

EMA looks to make its drug ap­proval process­es more ef­fi­cient

Zachary Brennan

Senior Editor

The Eu­ro­pean Med­i­cines Agency is look­ing to speed up its drug re­view time­lines, fol­low­ing a re­cent re­port show­ing how ap­pli­ca­tions can see long de­lays. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times